The lipid molecule, lysophosphatidylinositol (LPI), is hypothesised to form part of a novel lipid signalling system that involves the G protein-coupled receptor GPR55 and distinct intracellular signalling cascades in endothelial cells. This work aimed to study the possible mechanisms involved in LPI-evoked cytosolic Ca 
Introduction
There is increasing evidence that long-chain lipids have a wide variety of actions that are exerted through G protein-coupled receptors (Makide et al. 2014) . The bioactive lipid, lysophosphatidylinositol (LPI) is now accepted as an endogenous ligand of G proteincouple receptor GPR55. When LPI tested in systems expressing GPR55, it initiated responses, which were either absent in untransfected cells, diminished by siRNA knockdown of GPR55 or enhanced by GPR55 overexpression (Bondarenko et al. 2010 , Henstridge et al. 2009 , Oka et al. 2007 , Waldeck-Weiermair et al. 2008 . For instance, in HEK293 cells expressing a human GPR55 receptor, LPI induced Ca 2+ mobilization (Henstridge et al. 2009 ), caused phosphorylation of extracellular signal-regulated kinases (Oka et al. 2007 (Oka et al. , 2009 , and activated RhoA and nuclear factor of activated-T cells (Henstridge et al. 2009 ). Additionally, LPI initiated Ca 2+ mobilization in mice dorsal root ganglion neurons (Lauckner et al. 2008) and human endothelial cells naturally expressing GPR55 (Bondarenko et al. 2010 , Waldeck-Weiermair et al. 2008 . In human umbilical vein endothelial cells (HUVEC), LPI induced both GPR55-dependent and -independent signals (Bondarenko et al. 2010 , WaldeckWeiermair et al. 2008 , and acted as an intracellular messenger modulating Ca
2+
-activated K + channels (Bondarenko et al. 2011a) . The lipid also induced wound healing in primary human lung microvascular endothelial cells and causes platelets aggregation (Kargl et al. 2013) .
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With increasing evidence of vascular role of GPR55 and with lack of clarity of LPI action in vasculature, this study aims to further characterize the cellular action of LPI in endothelial cells. The intracellular Ca 2+ signals in response to LPI in human brain microvascular endothelial cells were investigated.
Methods

Cell culture
The human immortalised brain endothelial cell line (hCMEC/D3) was provided by Dr Margery Barrand, Department of Pharmacology, University of Cambridge. The cell line was originally donated by Dr Pierre Couraud (INSERM, rue de Tolbiac, Paris, France) and line was established from isolated human microvascular brain endothelial cells (Weksler et al. 2005) . The cells were grown on surfaces coated with 0.5 % bovine gelatine (Sigma), and were maintained in endothelial cell basal medium-2 (Lonza, Cologne, Germany) supplemented with 10 % (v/v) fetal bovine serum (FBS; Invitrogen) together with 100 U ml -1 penicillin, 100 μg ml -1 streptomycin, 2 mM L-glutamine, 80 µg ml -1 heparin, 5 µg ml -1 ascorbic acid (all from Sigma), and 75 µg ml -1 endothelial growth supplement (First Link, Birmingham). The cells were incubated at 37 °C in a humidified 5 % CO 2 atmosphere, and passaged when they reached ~90-95 % confluence. Experiments were conducted on cultures between passages 36 and 40.
Real-time PCR
Total RNA was extracted from the hCMEC/D3 cells using TRIZOL ® (Invitrogen) as explained in the manufacturer's protocol. Briefly, the cells at ~90 % confluence in T75 flasks were homogenised in 1 ml TRIZOL ® and total RNA was separated and precipitated and used to produce cDNA. Briefly, total RNA was subjected to DNase digestion before proceeding to cDNA synthesis using SuperScript TM II reverse transcriptase -free indicator, was measured in parallel wells treated with a combination of 0.05 % Triton X-100 and 10 mM BAPTA (Molekula, Gillingham, Dorset, UK). This background was subtracted from all measurements. Data were recorded on SoftMax Pro version 5.4 (Govindan et al. 2010) . Calcium Responses to LPI were recorded for a period of 5 min. Antagonists were incubated with cells for 10 min before being exposed to LPI.
Data and statistical analysis
In the population Ca 2+ assay, both basal and peak cytosolic free Ca 2+ concentrations were calculated using the formula: . n represents number of cells from at least 2 independent isolations.
In experiments where mRNA expression was examined, the authenticity of each product was assessed by melting-curve analysis and the results were analysed using the "comparative quantitation" feature of the RotorGene software. Concentration-response curves were analysed using 2-way ANOVA, and in those experiments where more than two groups were compared, statistical analysis was performed using one-way ANOVA followed by Bonferroni's post-hoc test. A P value of less than 0.05 was taken as statistically significant. Data were analysed using GraphPad Prism (GraphPad, San Diego, CA, USA).
Drugs
L-α-lysophosphatidylinositol, histamine (all from the Sigma Chemical Company, Poole, Dorset, UK) and Y-27632 (Tocris Cookson, Bristol, UK) were dissolved in distilled water. 2-aminoethoxydiphenyl borate (2-APB; from Tocris) was dissolved in 100 % ethanol. U 73122 (Tocris), U 73343 (Sigma), and thapsigargin (Sigma) were dissolved in 100 % dimethyl sulfoxide (DMSO). All solutions were prepared on the day of the experiment.
Results
Expression profile of GPR55, CB 1 and CB 2 receptors in hCMEC/D3 cell line
Expression of GPR55 and the cannabinoid receptors CB 1 and CB 2 in the hCMEC/D3 cell line was examined using qPCR. Analyses of the melting curves revealed single specific peaks beyond 80 °C. Low levels of mRNA transcripts for GPR55, CB 1 and CB 2 receptors were detected in this cell line and all the receptors were approximately equally expressed when compared to the reference gene β-actin (Fig. 1) .
Effect of histamine on [Ca
2+ ] i mobilization in hCMEC/D3 cells
In this study, the effect of histamine on cytosolic Ca 2+ mobilization was first tested before proceeding to examine the actions of LPI. In endothelial cells, histamine acts on H 1 -histamine receptors that are linked to the G αq -PLC-IP 3 pathway, resulting in elevation of [Ca 2+ ] i (Smit et al. 1999) . In the population Ca 2+ assay when extracellular Ca 2+ was present, histamine (10 µM)provoked a rapid rise in [Ca 2+ ] i which was characterised by a peak (218±30 nM) followed by a sustained phase ( Fig. 2A) . This latter phase disappeared when Ca 2+ -free buffer was used, indicating the need for Ca 2+ entry (Fig. 2B) . The downstream signalling pathway involved in the elevation of [Ca 2+ ] i was then investigated using enzyme inhibitors and receptor antagonists. As shown in Figure 2B and C, in nominally Ca 2+ -free HBS, the rise in [Ca 2+ ] i in response to histamine was abolished by depletion of intracellular Ca 2+ stores by thapsigargin
(1 µM), inhibition of PLC by U 73122 (10 µM) and antagonism of IP 3 receptors by 2-APB (100 µM). The selective inhibitor of the RhoA-specific kinase p160ROCK, Y-27632 (50 µM) had no effect on the histamine response. Figure 3 shows that, using the population Ca . The initial phase was rapid (~8 s following LPI application) and transient, whereas the late phase was characterised by a slowly developing, sustained, elevation of [Ca 2+ ] i following the rapid phase, which was only observed at higher concentrations (above 10 µM).
Characterization of LPI-evoked Ca 2+ transients in hCMEC/D3 cells
Effects of thapsigargin, 2-APB, U 73122, U 73343 and Y-27632 on the early phase of the Ca 2+ response
Since LPI induced a rise in [Ca 2+ ] i in which there were two peaks, the signalling pathway involved in each was studied independently. Pretreatment with thapsigargin (1 µM, 15 min incubation) attenuated the response to LPI (Fig. 4A ) and the IP 3 receptor antagonist, 2-APB (100 µM, 10-min incubation) also abolished the response (Fig. 4B) . The PLC inhibitor, U 73122 (10 µM, 10-min incubation) also abolished the rapid rise in [Ca 2+ ] i in response to LPI, whereas its inactive analogue, U 73343 (10 µM) had no effect (Fig. 5) . Treating the cells with 50 µM Y-27632 (20-min incubation) resulted in a significant reduction in the elevation of [Ca 2+ ] i by LPI (Fig. 6) . ]i responses were obtained in nominally Ca 2+ -free buffer. Each well of the 96-well plate was exposed to only a single concentration of LPI. 
Effect of thapsigargin, 2-APB, U 73122 and Y-27632 on the sustained Ca 2+ response to LPI
As mentioned above, the slowly developing, sustained, phase of the cytosolic Ca 2+ response to LPI was observed at higher concentrations of the lysolipid.
Interestingly, neither thapsigargin nor 2-APB, used at the same concentrations as above, had any noticeable effect on this phase in responses to 30 µM LPI (Fig. 7) . Even more interestingly, exposing the cells to 10 µM U 73122
for 10 min produced a prominent concentrationdependent potentiation of the slow phase of Ca 2+ signals evoked by LPI (Fig. 8) . On the other hand, Y-27632 (50 µM) abolished the sustained phase (Fig. 9) . 
Discussion
In endothelial cells, recent studies have shown that LPI induces intracellular Ca 2+ mobilization by activation of GPR55 (Bondarenko et al. 2010 , WaldeckWeiermair et al. 2008 ). The present study extends these observations to demonstrate that LPI initiates concentration-dependent cytosolic Ca 2+ mobilization in human brain microvascular endothelial cells (hCMEC/D3). The Ca 2+ signal evoked by LPI is characterised by a rapid phase of Ca 2+ release from the endoplasmic reticulum, and requires activation of the PLC-IP 3 signalling pathway and RhoA-dependent kinases. LPI also mediates a sustained phase of elevation of [Ca 2+ ] i which entirely depends on RhoA kinase activation.
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In hCMEC/D3 endothelial cells, LPI, concentration-dependently, stimulated biphasic elevation of cytosolic Ca 2+ . The rapid phase was characterised by a modest elevation of [Ca 2+ ] i (~40 nM at 30 µM LPI). Higher concentrations of LPI (>30 µM) were not tested due to the possibility of micelle formation beyond this concentration (Bondarenko et al. 2011b) . Since there was no obvious maximal effect at the highest concentration used, the EC 50 of LPI could not be determined in this population assay. The LPI-initiated rapid elevation of [Ca 2+ ] i was due to release from intracellular stores, as thapsigargin, the inhibitor of SERCA, attenuated the response. This was further confirmed by abolition of the signal by antagonism of the IP 3 receptor using 2-APB, suggesting release from endoplasmic reticulum. Moreover, to test if PLC was involved in this process, the cells were treated with U 73122, an inhibitor of PLC, at a concentration previously reported to inhibit the enzyme (Bleasdale et al. 1990 ] i is a receptor-initiated response, and involves activation of PLC-IP 3 pathway. In human endothelial cells, LPI, in addition to reported receptor-independent effects (including activation of nonselective cation channels, inhibition of Na + -K + ATPase, and bidirectional modulation of large-and intermediated-conductance Ca 2+ -activated K + channels) (Bondarenko et al. 2010 (Bondarenko et al. , 2011a , activates signalling through GPR55 (Bondarenko et al. 2010 , Waldeck-Weiermair et al. 2008 . There is an increasing body of evidence suggesting that GPR55 signals through G αq linked to PLC-IP 3 and G α12/13 linked to RhoA. GPR55 is possibly involved in the rapid phase of [Ca 2+ ] i stimulated by LPI in hCMEC/D3 cells, as its mRNA transcript was detected in this cell line. In order to further investigate this, the involvement of RhoA-dependent kinases was examined. Indeed, a selective inhibitor of RhoA-specific kinase (p160ROCK), Y-27632 significantly reduced the response, pointing to a likely role of this kinase. RhoAdependent Ca 2+ signalling through GPR55 has recently been suggested (Henstridge et al. 2009 ] i release, suggesting a possible role for RhoA kinases. Whether this effect is a receptor-mediated or not will require further studies to determine. In a recent work on LPI and endothelial cells (Al Suleimani and Hiley 2015) , similar findings were noticed in mesenteric endothelial cells. It was suggested that PLCε (which is regulated by RhoA) is the possible target in this phase. Further studies by using specific inhibitors of this PLC isoform will confirm this. Moreover, whether or not p160ROCK has direct regulatory activity on PLC, or indirectly through RhoA, is open to investigation. At least, this late phase of the Ca 2+ response seems to require activation of both PLC and RhoA. In the human umbilical vein endothelial cell line, EA.hy926, LPI induces GPR55-dependent and -independent elevation of cytosolic Ca 2+ (Bondarenko et al. 2010) . The receptor-dependent effect is sensitive to PLC inhibition while the receptor-independent effects involve activation of non-selective cation channels and inhibition of the Na + /K + -ATPase. The current study agrees with these findings in that LPI produced a biphasic effect on cytosolic Ca 2+ elevation that was characterised by an initial rapid peak, most probably mediated by GPR55, and a sustained phase which could be a GPR55-independent effect. In HEK293 cells expressing GPR55, LPI stimulates elevation of [Ca 2+ ] i that is oscillatory in nature (Henstridge et al. 2009 ). In our very recent published study (Al Suleimani and Hiley 2015) we have shown that LPI induced endothelium-dependent vasorelaxation of rat resistance mesenteric arteries and that the effect was independent of activation of guanylyl cyclase and cyclooxygenase metabolites, but largely involved activation of Ca 2+ -activated K + channels.
Overall, the experiments reported here on human brain microvascular endothelial cells show that LPI act as novel lipid signalling molecule, and elevation of cytosolic Ca 2+ triggered by it may present an important intracellular message required in gene expression and controlling of vascular tone.
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